ロード中...
Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature
Context: Metastatic pheochromocytoma/paraganglioma (MPP) therapy mainly involves radionuclide therapy, chemotherapy, and targeted therapy. In recent years, temozolomide (TMZ) showed great promise in some MMP patients, especially those with SDHB germline mutation. We reported a patient with MPP who d...
保存先:
| 出版年: | Front Endocrinol (Lausanne) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7040234/ https://ncbi.nlm.nih.gov/pubmed/32132978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00061 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|